That is very important, because the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work. Simply put, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure (jeff brown genome sequencing stock). And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much simpler to produce drugs that do what they're designed to do. This was a breakthrough almost nobody discovered. But it's going to have extensive implications for treating disease. I predict that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be plenty of financial investment chances in this space, too. Shifting topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (jeff brown genetic sequencing stock). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be surprised if it drew back perhaps substantially prior to going higher - jeff brown 1 biotech. I have actually been covering bitcoin for a long period of time now. Among the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mostly educating readers. But that's not the huge concern any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So consider that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. jeff brown 2021 stock picks. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are many great personal companies on the verge of striking the general public markets And I've been dealing with a brand-new way for you to invest even before these companies go public.
This chance has been building over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to reserve your spot free of charge.
Emma Walsh here, managing editor of the Diary. Regular Diary readers understand that tech isn't our typical beat (white house). And when it pertains to tech investing, we leave it to the experts. Thankfully, we have numerous such professionals in our Rolodex. Our coworker Jeff Brown will be familiar to our long time readers. He is one of the most accomplished tech investing professionals we understand (united states). In reality, he had a number of triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge image and anticipate what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and far more. These patterns are experiencing exponential development and developing amazing opportunities for financiers. I wish to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown predictions for 2021. But regardless of what numerous readers might believe, this is a pattern that's simply beginning. Even though the COVID-19 pandemic interfered with supply chains in 2015, an outstanding 250 million 5G-enabled devices were still offered.
And all of this ultimately resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by two months (biotech stock). Losing 2 months of production and sales truly affects the number of 5G gadgets are sold in the fiscal year. When you think about all of that, offering 250 million systems is exceptional. More significantly, the delays triggered by the pandemic produced a ton of pent-up need. And that need is now going to be pushed into 2021. In reality, I forecast that more than 500 million 5G devices will be delivered in 2021 - jeff brown 2021 stock predictions. Which's not my only 5G forecast When I've talked about 5G in the past, I've described its 3 different stages.
In Phase 2, 5G devices go on sale. 5G phones and other items start to reach consumers. And in Stage 3, 5G services begin to be provided (jeff brown tech stock 2021). That's when we begin to see applications running on 5G networks. Consider things like massive multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Phase 3 by this summer. This starts something of a virtuous cycle: Many people don't actually care about the innovation. But they will care if there are amazing applications that can just be accessed with a 5G phone.
That leads to more 5G apps being established. In truth, 5G is going to open up a suite of amazing applications: self-driving vehicles, the Internet of Things, robotic surgery, and more. All of these technologies need 5G. The financial investment chances going forward will be huge. Stepping far from 5G, the next crucial innovation I visualize in 2021 is CRISPR genetic editing. CRISPR represents "clustered routinely interspaced short palindromic repeat." It's a mouthful. However it's one of the most exciting developments in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software application.
The program can crash or not function correctly. CRISPR uses a similar concept but with our hereditary code. "Typos" in our genome can result in illness. CRISPR can fix these "typos." For many years, CRISPR was mainly a niche innovation that wasn't well comprehended. And during that time, there were actually just 3 companies running in this area. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual results. We're dealing with illness and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and providing unbelievable returns. This whole market is successfully a greenfield opportunity.
There's space for many business to exist in this area. what is the legacy report predicting. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or 3 more hereditary editing companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its latest Alpha, Fold software application can properly anticipate the folding of a protein based entirely on its amino acid series with 92. 4% precision. That's important due to the fact that the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been an experimental procedure. However now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're designed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one however a number of drug treatments produced using this innovation. This was one of those breakthroughs that practically no one noticed. However it's going to have extensive implications for treating disease. And, obviously, there will be a lot of investment chances in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it pulled back perhaps substantially prior to going greater. I have actually been covering bitcoin for a long time now. One of the very first research study reports I ever published was on bitcoin - jeff brown biotech picks. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my suggestion. But at the time of that initial suggestion, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However no one is asking that question anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. last year. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another reward prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the info is up to date since February 2021, but we might not independently confirm this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like ability to pick winning technology stocks. He spent more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an outstanding viewpoint on the market. He's always on the hunt for brand-new opportunities, and he shares a lot of his finest choices in the Future Report.
That's high appreciation, but it's not absurdly reasoned. Brown has an excellent track record as a stock-picker, and he successfully anticipated a few of the biggest economic events of the past 20 years. Although he doesn't appear to release his picks to the general public, the service's success is a direct indication of Brown's stock-picking prowess. Nobody on Wall Street gets it best whenever, but Jeff Brown's precise predictions have actually made him legions of devoted followers. That states a lot about his ability. The Near Future Report is published by Brownstone Research study, a popular financial research publisher. Brownstone Research study uses numerous research study services with a variety of expertises - jeff brown latest prediction.
The company is also associated with Bonner & Partners, another well-respected research study publisher - exponential growth. On its site, Brownstone says its mission is to provide retail financiers with professional-grade research study: "For too long, the best investment research has actually not been readily available to individual investors. It has been usually reserved for investment banks, hedge funds, private equity, and high-net-worth clients. jeff brown. The objective of Brownstone Research study is to make that type of exclusive research study offered to any financiers looking to gain an edge in the markets. The objective is simple to deliver special and successful financial investment research study found nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also acts as the company's Chief Financial investment Expert.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to offer its customers. After decades of steady success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout most of America. If you know even a little bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. white house. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In truth, Brown believes S.A.V. jeff brown predictions for 2021. could be "the biggest pattern of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding two cutting-edge technologies: expert system and electrical cars and trucks. Musk hopes the combination will assist him establish the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing brief of the vehicle industry's Holy Grail. As you know, electrical cars and self-driving cars and truck stocks have actually been substantial this year, but the Wall Street device has been huge on hype without much concrete result. Despite an extreme boost in competitors over the previous few years, Brown still believes Musk has the very best chance of putting everything together.
tech might be the magic string that ties all of it together. S.A.V. means Shared Autonomous Automobile, and it might be the future of transport. Generally, this innovation would allow you to lease your cars and truck as an autonomous, self-driving taxi when you're not utilizing it. You simply get out of the cars and truck and press a button on an app that informs the automobile to "join the fleet." Next thing you know, you're relaxing on your couch while your vehicle shuttles ride-sharers around town. Best of all, you get to keep a significant portion of the profits. It sounds ridiculous, but it could be closed than you think.